Available Until 12/31/2025

Pharmacogenomics Education Series

Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists

Activity Date: September 15, 2017
Expiration Date: December 31, 2025
Activity Type: Knowledge-based   
Activity Fee: Member – Free / Non-member – N/A 

Activity Overview

The Pharmacogenomics Webinar Series was created by content matter experts practicing in clinics, research, academia, and inpatient areas across the United States and is maintained and curated by the Section of Clinical Specialists and Scientist’s Advisory Group on Emerging Sciences. 

The sessions below cover everything from starting a pharmacogenomics program, teaching pharmacogenomics to students and patients, as wells as pharmacogenomics considerations for specific clinical conditions.

This series is free for ASHP members as a benefit of membership. 

Activities & Faculty

Introduction to Pharmacogenomics 
CE Activity Annoucement

  • Vicki Ellingrod, Pharm.D., Professor, University of Michigan College of Pharmacy
  • J. Kevin Hicks, Pharm.D., Ph.D., Personalized Medicine Specialist, DeBartolo Family Personalized Medicine Institute, H.Lee Moffitt Cancer Center & Research Institute

Building a Pharmacogenomics Program

  • Howard L. McLeod, Pharm.D., FCCP, Medical Director, DeBartolo Family Personalized Medicine Institute, H.Lee Moffitt Cancer Center & Research; Senior Member, Cancer Epidemiology, State of Florida Endowed Chair in Cancer Research; Professor, College of Medicine and Pharmacy, University of South Florida

Cardiology I: Clopidogrel & Simvastatin

  • Larisa Cavallari, Pharm.D., Associate Professor, Department of Pharmacotherapy and Translational Research, University of Florida; Associate Director, UF Health Personalized Medicine Program; Director, UF Center for Pharmacogenomics

Cardiology II: Warfarin

  • Larisa Cavallari, Pharm.D., Associate Professor, Department of Pharmacotherapy and Translational Research, University of Florida; Associate Director, UF Health Personalized Medicine Program; Director, UF Center for Pharmacogenomics

Clinical Resources: CPIC & PharmGKB

  • Kelly E. Caudle, Pharm.D., Ph.D., BCPS, Assistant Professor, University of Tennessee Health Science Center

Implementation in a Community Setting

  • Gillian Bell, Pharm.D., Clinical Pharmacist, Mission Personalized Medicine Program, Mission Health

Implementation in a Large Academic Center

  • J. Kevin Hicks, Pharm.D., Ph.D., Personalized Medicine Specialist, DeBartolo Family Personalized Medicine Institute, H.Lee Moffitt Cancer Center & Research Institute

Implementation in an Outpatient Setting

  • H. Mark Dunnenberger, Pharm.D., Senior Clinical Specialist Pharmacogenomics, NorthShore Center for Personalized Medicine NorthShore Health System

Infectious Disease: CYP2C19 & Voriconazole

  • Kelly E. Caudle, Pharm.D., Ph.D., BCPS, Assistant Professor, University of Tennessee Health Science Center

Infectious Disease: HIV

  • Jason J. Schafer, Pharm.D., M.P.H., BCPS, AAHIVP, Associate Professor, Department of Pharmacy Practice, Jefferson College of Pharmacy

Oncology I: Tamoxifen & Irinotecan

  • Daniel Hertz, Pharm.D., Ph.D., Assistant Professor, Department of Clinical Pharmacy, Universityof Michigan College of Pharmacy

Oncology II: Tiopurines & Fluoropyrimidines

  • Cyrine E. Haidar, Pharm.D., BCPS, BCOP, Clinical Pharmacogenetics Coordinator, St. Jude Children’s Research Hospital; Assistant Professor, University of Tennessee Health Science Center

Oncology III: Somatic Genomics

  • Christine Walko, Pharm.D., BCOP, FCCP, Personalized Medicine Specialist, Chair, Clinical Genomic Action Committee, DeBartolo Family Personalized Medicine
    Institute, H.Lee Moffitt Cancer Center & Research

Pain Management

  • Kristine R. Crews, Pharm.D., BCPS, FCCP, Translational Research Laboratory Director, Pharmaceutical Sciences Department, Director, PGY2 Residency in Clinical Pharmacogenetics, St. Jude Children’s Research Hospital

Patient Education

  • Aniwaa Owusu Obeng, Pharm.D., Clinical Pharmacogenomics Coordinator in the Pharmacy Department at The Mount Sinai Hospital; Assistant Professor, Icahn School of Medicine, Mount Sinai in The Charles Bronfman Institute for Personalized Medicine

Psychiatry

  • Jeffrey R. Bishop, Pharm.D., M.S., BCPP, Associate Professor of Pharmacy and Psychiatry, University of Minnesota

Teaching Pharmacogenomics to Students

  • Philip Empey, Pharm.D., Ph.D., Assistant Professor,, Department of Pharmacy & Therapeutics; Associate Director, Institute of Precision Medicine, University of Pittsburgh

Transplant

  • Christina Aquilante, Pharm.D., FCCP, Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences